SynBiotic SE (SBX.DE)

EUR 4.6

(-3.97%)

Operating Expenses Summary of SynBiotic SE

  • SynBiotic SE's latest annual operating expenses in 2023 was 1.5 Million EUR , down -56.11% from previous year.
  • SynBiotic SE's latest quarterly operating expenses in 2023 FY was 12.71 Million EUR , down -56.11% from previous quarter.
  • SynBiotic SE reported a annual operating expenses of 28.97 Million EUR in annual operating expenses 2022, up 74.19% from previous year.
  • SynBiotic SE reported a annual operating expenses of 16.63 Million EUR in annual operating expenses 2021, up 273.04% from previous year.
  • SynBiotic SE reported a quarterly operating expenses of - EUR for 2023 Q2, down 0.0% from previous quarter.
  • SynBiotic SE reported a quarterly operating expenses of 1.15 Million EUR for 2022 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of SynBiotic SE (2023 - 2018)

Historical Annual Operating Expenses of SynBiotic SE (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 1.5 Million EUR -56.11%
2022 28.97 Million EUR 74.19%
2021 16.63 Million EUR 273.04%
2020 4.45 Million EUR 33109.04%
2019 13.42 Thousand EUR 1533.7%
2018 822.00 EUR 0.0%

Peer Operating Expenses Comparison of SynBiotic SE

Name Operating Expenses Operating Expenses Difference
MPH Health Care AG 4.22 Million EUR 64.316%
Apontis Pharma AG 23.17 Million EUR 93.499%
Dermapharm Holding SE 142.51 Million EUR 98.943%
Evotec SE 222.55 Million EUR 99.323%
MERCK Kommanditgesellschaft auf Aktien 8.82 Billion EUR 99.983%
PharmaSGP Holding SE 50.72 Million EUR 97.03%